S. Brown

发表

Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection

Dominique Schols, M. Lederman, C. Flexner, 2004, Journal of acquired immune deficiency syndromes.

An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy.

D. Simpson, L. Estanislao, J. Sampson, 2008, Journal of pain and symptom management.

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

Jack T Stapleton, Stuart Haber, David Heckerman, 2010, Science.

Mechanisms of HIV Receptor and Co-Receptor Down-Regulation by Prostratin: Role of Conventional and Novel PKC Isoforms

M. Foti, S. Mouche, I. Szanto, 2004, Antiviral chemistry & chemotherapy.

A Randomized, Double-Blind, Controlled Study of NGX-4010, a Capsaicin 8% Dermal Patch, for the Treatment of Painful HIV-Associated Distal Sensory Polyneuropathy

D. Clifford, B. Conway, D. Simpson, 2012, Journal of acquired immune deficiency syndromes.

The Slippery Slope: Lubricant Use and Rectal Sexually Transmitted Infections: A Newly Identified Risk

R. Weiss, E. Fuchs, P. Anton, 2012, Sexually transmitted diseases.

Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.

D. Simpson, L. Webster, J. Tobias, 2010, Journal of pain and symptom management.

Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.

J. Kublin, D. Mehrotra, J. Shiver, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

CD4 on CD8(+) T cells directly enhances effector function and is a target for HIV infection.

J. Zack, D. Brooks, C. Kitchen, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Dual Role of Prostratin in Inhibition of Infection and Reactivation of Human Immunodeficiency Virus from Latency in Primary Blood Lymphocytes and Lymphoid Tissue

J. Grivel, L. Margolis, I. Hirsch, 2004, Journal of Virology.

Prostratin Induces HIV Activation and Downregulates HIV Receptors in Peripheral Blood Lymphocytes

J. Alcamí, Stephen J Brown, M. Hezareh, 2004, Antiviral therapy.

Effects of Prostratin on T-Cell Activation and Human Immunodeficiency Virus Latency

Y. Korin, J. Zack, D. Brooks, 2002, Journal of Virology.

Latency and Human Immunodeficiency Virus Effects of Prostratin on T-Cell Activation

Y. Korin, J. Zack, D. Brooks, 2002 .

Sexual Risk Behaviors, Circumcision Status, and Preexisting Immunity to Adenovirus Type 5 Among Men Who Have Sex With Men Participating in a Randomized HIV-1 Vaccine Efficacy Trial: Step Study

S. Buchbinder, K. Mayer, Jorge Sanchez, 2012, Journal of acquired immune deficiency syndromes.

Recombinant Human Growth Hormone to Treat HIV-Associated Adipose Redistribution Syndrome: 12-Week Induction and 24-Week Maintenance Therapy

C. Grunfeld, D. Kotler, Stephen J Brown, 2007, Journal of acquired immune deficiency syndromes.

Efficacy and Safety of Crofelemer for Noninfectious Diarrhea in HIV-Seropositive Individuals (ADVENT Trial): A Randomized, Double-Blind, Placebo-Controlled, Two-Stage Study

A. LaMarca, C. Paterson, E. Bortey, 2013, HIV clinical trials.

Safety, pharmacokinetics, and antiviral activity of HGS004, a novel fully human IgG4 monoclonal antibody against CCR5, in HIV-1-infected patients.

M. Lederman, L. Novello, M. Para, 2008, The Journal of infectious diseases.

Recruitment and Baseline Epidemiologic Profile of Participants in the First Phase 3 HIV Vaccine Efficacy Trial

J. Kostman, K. Mayer, B. Bartholow, 2004, Journal of acquired immune deficiency syndromes.

Potent and Selective Inhibition of HIV and SIV by Prostratin Interacting with Viral Entry

E. De Clercq, C. Pannecouque, M. Witvrouw, 2003, Antiviral chemistry & chemotherapy.

Order of Orifices: Sequence of Condom Use and Ejaculation by Orifice During Anal Intercourse Among Women Implications for HIV Transmission

R. Weiss, E. Fuchs, P. Anton, 2014, Journal of acquired immune deficiency syndromes.

Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment.

L. Schneider, R. Heaton, J. Rochon, 1998, Archives of neurology.

The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

R. C. Rose, Todd M. Allen, David S. Rubin, 2010, Science.